J Low Genit Tract Dis. 2023 Jul 1;27(3):202-206. doi: 10.1097/LGT.0000000000000730. Epub 2023 Mar 22.
This study aimed to investigate the diagnostic value of atypical glandular cells (AGCs) by analyzing the prevalence and histopathology of AGCs according to cervical cytology.
The authors retrospectively reviewed and analyzed the demographic characteristics and histopathological outcomes including pathological diagnosis, pathological site, and epithelial distribution of the AGC cases that were diagnosed by cervical cytology.
A total of 387 AGC patients with follow-up records were included. Among them, the prevalence of AGC-not otherwise specified (NOS) and AGC-favor neoplastic (FN) was 73.39% (284/387) and 26.62% (103/387), respectively. The high-risk human papillomavirus (hr-HPV)-positive rate was higher in AGC-FN than in AGC-NOS ( p = .002). The difference in pathological severity was statistically significant between hr-HPV-positive and negative AGC patients ( p = .010). Hr-HPV-positive AGC mainly occurs in cervical diseases, whereas hr-HPV-negative AGC is mainly related to endometrial lesions. Precancerous or malignant lesions were found in 36.43% (141/387) of AGC cases and were more commonly seen in AGC-FN than AGC-NOS ( p < .001). The histopathological severity and the incidence of uterine disease were higher among AGC women aged 40 years and older than those younger than 40 years ( p < .05). The possibility of the abnormal origin of glandular epithelial was higher than that of squamous epithelial in AGC patients aged 40 years and older ( p = .0003).
The management of AGC women by age triage is reasonable because the incidence of the glandular epithelial lesion and uterine disease increases in AGC patients 40 years or older. Standardized clinical diagnosis and regular follow-up are recommended for all AGC patients.
本研究旨在通过分析宫颈细胞学检查中不典型腺细胞(AGC)的流行情况和组织病理学,探讨其诊断价值。
作者回顾性分析了经宫颈细胞学检查诊断为 AGC 的患者的人口统计学特征及组织病理学结果,包括病理诊断、病变部位及上皮分布。
共纳入 387 例有随访记录的 AGC 患者,其中 AGC 非特指型(AGC-NOS)和 AGC 倾向于肿瘤(AGC-FN)的检出率分别为 73.39%(284/387)和 26.62%(103/387)。AGC-FN 患者高危型人乳头瘤病毒(hr-HPV)阳性率高于 AGC-NOS 患者(p=0.002)。hr-HPV 阳性和阴性 AGC 患者的病理严重程度差异有统计学意义(p=0.010)。hr-HPV 阳性 AGC 主要发生在宫颈疾病,而 hr-HPV 阴性 AGC 主要与子宫内膜病变相关。36.43%(141/387)的 AGC 患者发现癌前或恶性病变,且 AGC-FN 患者多于 AGC-NOS 患者(p<0.001)。40 岁及以上 AGC 患者的组织病理学严重程度和子宫疾病发生率均高于 40 岁以下患者(p<0.05)。40 岁及以上 AGC 患者腺上皮异常起源的可能性高于鳞上皮(p=0.0003)。
对 AGC 患者进行年龄分层管理是合理的,因为 40 岁及以上 AGC 患者的腺上皮病变和子宫疾病发生率增加。建议对所有 AGC 患者进行标准化临床诊断和定期随访。